Moderna (MRNA) Earnings Date, Estimates & Call Transcripts $41.11 +2.86 (+7.48%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Moderna Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 27EstimatedActual EPS (Nov. 7) $0.03 Beat By $1.92 Consensus EPS (Nov. 7) -$1.89 Moderna posted Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.03, which topped analysts' consensus estimates of -$1.89 by $1.92. Quarterly revenue rose 3.8% year-over-year to $1.90 billion, above analyst estimates of $1.25 billion. With a trailing EPS of -$5.82, Moderna's earnings are expected to grow next year, from ($9.44) to ($8.70) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckMRNA Upcoming EarningsModerna's next earnings date is estimated for Thursday, February 27, 2025, based off prior year's reporting schedules. Get Moderna Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moderna and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Moderna Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244-$3.49-$1.86-$2.66Q2 20244-$3.47-$1.85-$3.02Q3 20244-$1.88$0.10-$0.97Q4 20244-$1.83$1.60-$0.38FY 202416-$10.67-$2.01-$7.02Q1 20251-$2.90-$2.90-$2.90Q2 20251-$3.11-$3.11-$3.11Q3 20252-$1.44$1.30-$0.07Q4 20252-$1.25$1.36$0.06FY 20256-$8.70-$3.35-$6.03Q1 20261-$2.68-$2.68-$2.68Q2 20261-$2.76-$2.76-$2.76Q3 20261-$0.72-$0.72-$0.72 Moderna Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/27/2025(Estimated)------- 11/7/2024Q3 2024-$1.89$0.03+$1.92$0.03$1.25B$1.90B 8/1/2024Q2 2024-$3.47-$3.33+$0.14-$3.33$128.41M$241.00M 5/2/2024Q1 2024-$3.59-$3.07+$0.52-$3.07$93.26M$167.00M 2/22/2024Q4 2023-$0.78$0.55+$1.33$0.55$2.53B$2.80B 11/2/2023Q3 2023-$2.01-$1.39+$0.62$6.75$1.37B$1.83B 8/3/2023Q2 2023-$3.84-$3.62+$0.22-$3.62$307.67M$344.00M Get the Latest News and Ratings for MRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$1.77$0.19+$1.96$0.19$1.17B$1.86B 2/23/2023Q4 2022$4.66$3.61 -$1.05$3.61$5.02B$5.08B Moderna Earnings - Frequently Asked Questions When is Moderna's earnings date? Moderna has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates. Learn more on MRNA's earnings history. What guidance has Moderna issued on next quarter's earnings? Moderna issued an update on its FY 2025 earnings guidance on Thursday, September, 12th. The company issued revenue guidance of $2.5 billion-$3.5 billion, compared to the consensus revenue estimate of $3.7 billion. Did Moderna beat their earnings estimates last quarter? In the previous quarter, Moderna (NASDAQ:MRNA) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.89) by $1.92. Learn more on analysts' earnings estimate vs. MRNA's actual earnings. How can I listen to Moderna's earnings conference call? The conference call for Moderna's latest earnings report can be listened to online. Listen to Conference Call How can I read Moderna's conference call transcript? The conference call transcript for Moderna's latest earnings report can be read online. Read Transcript How much revenue does Moderna generate each year? Moderna (NASDAQ:MRNA) has a recorded annual revenue of $5.06 billion. How much profit does Moderna generate each year? Moderna (NASDAQ:MRNA) has a recorded net income of -$4.71 billion. MRNA has generated -$5.82 earnings per share over the last four quarters. What is Moderna's EPS forecast for next year? Moderna's earnings are expected to grow from ($9.44) per share to ($8.70) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Neurocrine Biosciences Earnings Date Bio-Techne Earnings Date Repligen Earnings Date Biogen Earnings Date CRISPR Therapeutics Earnings Date Denali Therapeutics Earnings Date Takeda Pharmaceutical Earnings Date BioNTech Earnings Date Teva Pharmaceutical Industries Earnings Date BeiGene Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A “Thank You Gift” From Pres. Trump - Genius (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NASDAQ:MRNA) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
